Aichi, Japan

Mitsuaki Nagasaka

This inventor holds 6 USPTO granted patents. Top assignees: Maruko Seiyaku Co., Ltd., Taiho Pharmaceutical Company Limited. Active years: 1976-1987.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Mitsuaki Nagasaka. Retrieved from https://idiyas.com/inventor/mitsuaki-nagasaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.4

ph-index = 3

Forward Citations = 20(Granted Patents)


Location History:

  • Aichi, JA (1976)
  • Aichi, JP (1981 - 1987)

Company Filing History:


Years Active: 1976-1987

Loading Chart...
6 patents (USPTO):Explore Patents

Title: Mitsuaki Nagasaka: Innovator in Pharmaceutical Chemistry

Introduction

Mitsuaki Nagasaka is a prominent inventor based in Aichi, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative patents. With a total of 6 patents, Nagasaka has focused on developing novel compounds that address various health issues.

Latest Patents

Nagasaka's latest patents include the development of ergoline derivatives and acid addition salts thereof. These novel ergoline derivatives exhibit excellent anti-hypertensive activity, vasodilating activity, anti-ulcer activity, gastric secretion inhibitory activity, brain metabolism improving activity, anti-depressive activity, and dopamine-like activity. As a result, they are useful for the prevention and treatment of various diseases such as hypertension, vein disorders, peptic ulcers, brain abnormalities, depression, Parkinson's disease, and high prolactin blood disease. Another significant patent involves certain pyridyloxy-or-thio-phenyl propenoic acid derivatives. These novel pyridine compounds and their pharmaceutically acceptable salts possess specific inhibitory activity on thromboxane A2 biosynthesis in mammals. They are beneficial for preventing and treating disorders caused by thromboxane A2, including thrombosis, cardiac infarction, diabetic vascular complications, and asthma.

Career Highlights

Throughout his career, Nagasaka has worked with notable companies such as Maruko Seiyaku Co., Ltd. and Taiho Pharmaceutical Company Limited. His work in these organizations has allowed him to further his research and development in pharmaceutical innovations.

Collaborations

Nagasaka has collaborated with esteemed colleagues, including Sachio Ohno and Kiyoshi Mizukoshi. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

Mitsuaki Nagasaka is a distinguished inventor whose work in pharmaceutical chemistry has led to the creation of innovative compounds with significant therapeutic potential. His contributions continue to impact the field positively, addressing critical health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…